PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 31, 2026Journal of the American College of Cardiology0 citations

Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy

View Full Paper
MDMilind Y. DesaiAOAnjali OwensPGPablo Garcia-Pavia

Key Points

Key points are not available for this paper at this time.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Desai et al. (2026) studied this question.

synapsesocial.com/papers/6a025cdaedf6f48138594a65https://doi.org/10.1016/j.jacc.2025.12.092
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 12023 ESC Guidelines for the management of cardiomyopathies2023 · 2,663 citations
  2. 2Long-term effect of mavacamten in obstructive hypertrophic cardiomyopathy2024 · 103 citations
  3. 3Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy2025 · 67 citations
  4. 4Echocardiographic Changes With Mavacamten in Nonobstructive Hypertrophic Cardiomyopathy2025 · 15 citations
  5. 5Effects of Mavacamten on Cardiac Biomarkers in Nonobstructive Hypertrophic Cardiomyopathy2025 · 12 citations